(Q37196387)

18 August 2017

1 reference

title

'Recurrent' glioblastoma multiforme, when should we reoperate? (English)

1 reference

18 August 2017

1 reference

Giuseppe M V Barbagallo

series ordinal

1

1 reference

18 August 2017

Michael D Jenkinson

series ordinal

2

1 reference

18 August 2017

Andrew R Brodbelt

series ordinal

3

1 reference

18 August 2017

1 June 2008

1 reference

British Journal of Neurosurgery

18 August 2017

1 reference

18 August 2017

22

1 reference

18 August 2017

3

1 reference

18 August 2017

452-455

1 reference

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

18 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Glioblastoma--the consequences of advanced patient age on treatment and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Glioma extent of resection and its impact on patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Survival and functional status after resection of recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Evidence-based review of the role of reoperation in the management of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Advanced MRI in the management of adult gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Dynamic susceptibility contrast MRI of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Management of malignant glioma: steady progress with multimodal approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

A comparison of treatment results for recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

Salvage therapy in patients with glioblastoma: is there any benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690802182256

10.1080/02688690802182256

21 January 2018

Identifiers

DOI

1 reference

release_exsjseyuyrgiha4rb3o6wcrjtq

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/exsjseyuyrgiha4rb3o6wcrjtq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference